TERRAMYCIN W Drug Patent Profile
✉ Email this page to a colleague
When do Terramycin W patents expire, and what generic alternatives are available?
Terramycin W is a drug marketed by Pfizer and Casper Pharma Llc and is included in two NDAs.
The generic ingredient in TERRAMYCIN W is oxytetracycline hydrochloride; polymyxin b sulfate. There are thirty-six drug master file entries for this compound. Additional details are available on the oxytetracycline hydrochloride; polymyxin b sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TERRAMYCIN W?
- What are the global sales for TERRAMYCIN W?
- What is Average Wholesale Price for TERRAMYCIN W?
Summary for TERRAMYCIN W
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| DailyMed Link: | TERRAMYCIN W at DailyMed |
US Patents and Regulatory Information for TERRAMYCIN W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | TERRAMYCIN W/ POLYMYXIN | oxytetracycline hydrochloride; polymyxin b sulfate | OINTMENT;OTIC | 061841-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Casper Pharma Llc | TERRAMYCIN W/ POLYMYXIN B SULFATE | oxytetracycline hydrochloride; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 061015-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
